Part One of Coventry’s 2017 Drug Trends Series reported the largest drop in Morphine Equivalent Dose (MED) in the last three years. As an indicator of increased chances for adverse outcomes, including death from overdose, these and other inroads are essential in the effort to curtail opioid misuse. To learn more about MED and its impact watch our latest video blog.
SAN DIEGO, CA—November 3, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
In workers’ compensation, catastrophic injuries transpire with relatively low frequency.
SAN DIEGO, CA—October 26, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
When adjusters have to jump through hoops to make referrals, they lose precious time.
